Transcatheter Mitral Valve Implantation (TMVI)

Transcatheter Mitral Valve Implantation (TMVI) meeting comprised of three presentations and subsequent panel discussions on a range of topical issues related to treatment strategies in mitral valve disease.

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport


During PCR London Valves 2014 (UK), Radcliffe Cardiology, in association with the Interventional Cardiology Review journal, filmed a roundtable discussion entitled 'Transcatheter Mitral Valve Implantation (TMVI)'.

  •  SESSION 1 / Mitral Valve Surgery
  •  SESSION 2 / Mitral Valve Modification
  •  SESSION 3 / Redo & De Novo Implantation


The discussion was moderated by Simon Kennon (London, UK). He was joined by expert group of physicians including Profs. Inderpaul Birdi (Basildon, UK), Georg Lutter (Kiel, DE), Darren Mylotte (Galway, IE), Neil E Moat (Harefield, UK), Lars Søndergaard (Copenhagen, DK) and Nina Wunderlich(Darmstadt, DE).

Simon Kennon, Interventional Cardiologist and Head of the Transcatheter Aortic Valve Implantation Programme, London Chest Hospital, London, UK
Inderpaul Birdi, Essex Cardiothoracic Centre, UK
Georg Lutter, Christian-Albrechts-University of Kiel, Germany
Neil E Moat, Royal Brompton & Harefield NHS Trust, UK
Darren Mylotte, Galway University Hospitals, Eire
Lars Søndergaard, Rigshospitalet University Hospital, Denmark
Nina Wunderlich, Cardiovascular Center Darmstadt, Germany

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport

Target Audience

This educational activity is intended for an international audience of interventional cardiologists, cardiac surgeons and heart failure specialists. It would also be of benefit to cardiologists looking to increase their knowledge on this novel area of cardiovascular intervention.

Learning Objectives

The assigned learning objectives for this roundtable are listed for your information:


  • Mitral Valve Anatomy
  • Mitral valve surgery (repair, replacement, annuloplasty)
  • Minimally invasive mitral valve surgery
  • Surgical outcome figures
  • Who is not amenable to surgery?


  • Overview of available technologies
  • Patient selection and assessment
  • Summary of procedures, success rates and complications
  • Short and medium term outcomes
  • What’s in the pipeline?

The third and final session focuses on the exciting, emerging field of transcatheter mitral valve interventions. The expert panel discuss both Redo & De Novo implantation, available and emerging technologies, procedural limitations, success rates, complications and patient selection.

Loading Simple Education